A delegation from the Department of Medical Research, Ministry of Health, Myanmar, visited and observed operations at CytoAurora Biotechnology (Thailand) Co., Ltd.
Today (February 12th, 2026), a delegation from the Department of Medical Research, Ministry of Health Myanmar, led by Prof. Dr. Aye Aye Khin, Director General, visited CytoAurora Biotechnology (Thailand) Co., Ltd. to observe ours operations.
Dr. Huang Chung-Erh, Managing Director of CytoAurora Biotechnology (Taiwan) Co., Ltd., presented the innovative Circulating Tumor Cells (CTCs) detection system using the Nano CAST™ Cancer Solution and demonstrated the procedures and analytical processes to the delegation.
The company is committed to developing and transferring innovations to advance cancer diagnosis and patient care, while promoting sustainable international collaboration in public health.
CytoAurora Biotechnology (Thailand) Co., Ltd. is deeply honored by the interest shown by the delegation and is very pleased to have had the opportunity to extend a warm welcome on this occasion.